p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma
Authors:
- 24 February 2015
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 22 (5) , 447-453
Abstract
Objectives: To estimate the impact of p21‐activated kinase 1 expression on recurrence and survival of patients with non‐metastatic clear cell renal cell carcinoma after surgical resection.Methods: We retrospectively enrolled 254 patients (187 in the training cohort and 67 in the validation cohort) with non‐metastatic clear cell renal cell carcinoma undergoing nephrectomy at a single institution. Clinicopathological features, overall survival and recurrence‐free survival were recorded. p21‐activated kinase 1 intensities were assessed by immunohistochemistry of patients' specimens. The Kaplan–Meier method was applied to compare survival curves. Cox regression models were used to analyze the impact of prognostic factors on overall survival and recurrence‐free survival. The concordance index was calculated to assess predictive accuracy.Results: In both cohorts, elevated p21‐activated kinase 1 expression in tumor tissues positively correlated with advanced T stage and Fuhrman grade. High p21‐activated kinase 1 expression indicated poor survival and early recurrence of patients with non‐metastatic clear cell renal cell carcinoma, especially with early T1–2 stage disease. After backward elimination, p21‐activated kinase 1 expression was identified as an independent adverse prognostic factor for survival and recurrence. The predictive accuracy of the traditional University of California Integrated Staging System and Mayo Clinic stage, size, grade and necrosis prognostic models was improved when p21‐activated kinase 1 expression was added.Conclusions: Elevated expression of p21‐activated kinase 1 seems to be an independent adverse prognostic biomarker for recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma after nephrectomy.Keywords
This publication has 30 references indexed in Scilit:
- Prognostic Models and Factors for Patients with Renal-Cell Carcinoma: A Survey on Their Use Among UrologistsJournal of Endourology, 2013
- PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer CellsPLOS ONE, 2012
- Hepatitis B Virus X Protein Confers Resistance of Hepatoma Cells to Anoikis by Up-regulating and Activating p21-Activated Kinase 1Gastroenterology, 2012
- PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingOncogene, 2011
- Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cellsProceedings of the National Academy of Sciences, 2011
- Biological determinants of endocrine resistance in breast cancerNature Reviews Cancer, 2009
- Development and evaluation of BioScoreCancer, 2009
- Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical ApplicabilityEuropean Urology, 2009
- Modulation of p21‐activated kinase 1 alters the behavior of renal cell carcinomaInternational Journal of Cancer, 2007
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004